SCHEMBL623882

SCHEMBL623882

CN(c1nn2c(-c3cccc(C(F)(F)F)c3)cnc2s1)C1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.46
DYRK2 Q92630 4/20 0.46
CCNA2 P20248 3/20 0.45
CDK2 P24941 3/20 0.45
CDK5 Q00535 3/20 0.45
CDK5R1 Q15078 3/20 0.45
DYRK1B Q9Y463 3/20 0.45
DYRK3 O43781 2/20 0.45
CCNT1 O60563 2/20 0.45
CDK9 P50750 2/20 0.45
PIM1 P11309 10/20 0.44
KCNH2 Q12809 2/20 0.44
PIM3 Q86V86 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
FYN P06241 3/20 0.43
PLAT P00750 2/20 0.43
AURKA O14965 1/20 0.42
FLT3 P36888 1/20 0.42
GSK3B P49841 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2251446 0.94 DYRK1A (0.49) DYRK1ADYRK2CCNA2CDK2CDK5
SCHEMBL625503 0.86 PIM1 (0.52) DYRK1APIM1KCNH2FYN
SCHEMBL1947244 0.81 FYN (0.57) PIM1FYN
SCHEMBL2257597 0.80 DYRK1A (0.44) DYRK1ADYRK2CCNA2CDK2CDK5
SCHEMBL625653 0.80 PIK3CA (0.54)
SCHEMBL1945252 0.80 DYRK1A (0.52) DYRK1APIM1KCNH2PIM3PIM2
SCHEMBL27815636 0.78 DYRK3 (0.46) DYRK1ADYRK2CCNA2CDK2CDK5
SCHEMBL15603239 0.78 DYRK1A (0.46) DYRK1ADYRK2CCNA2CDK2CDK5
SCHEMBL1944248 0.78 FYN (0.43) FYN
SCHEMBL623881 0.77 FYN (0.60) PIM1KCNH2PIM3PIM2FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed